Security
Sanara MedTech Inc. Common Stock · SMTI
SMTINASDAQCommon stockCurrentCIK 714256Updated Oct 30, 2026
Name history
WOUND MANAGEMENT TECHNOLOGIES, INC. · through Apr 3, 2019MB SOFTWARE CORP · through Jun 10, 2008INAV TRAVEL CORPORATION · through May 3, 1996
SMTI price & chart
Loading TradingView…
NASDAQ:SMTI on TradingView ↗About the company
Sanara MedTech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skin markets. The Company markets, distributes and develops surgical, wound and skin products for use by physicians and clinicians in hospitals, clinics and all post-acute care. Sanara’s products are primarily sold in the North American advanced wound care and surgical tissue repair markets. Sanara markets and distributes CellerateRX ® Surgical Activated Collagen ®, FORTIFY TRG ® Tissue Repair Graft and FORTIFY FLOWABLE ® Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN™ Verified Inductive Bone Matrix, ALLOCYTE ® Plus Advanced Viable Bone Matrix, BiFORM ® Bioactive Moldable Matrix, TEXAGEN ® Amniotic Membrane Allograft, and BIASURGE ® Advanced Surgical Solution to the surgical market. In addition, the following products are sold in the wound care market: BIAKŌS ® Antimicrobial Skin and Wound Cleanser, BIAKŌS ® Antimicrobial Wound Gel, and BIAKŌS ® Antimicrobial Skin and Wound Irrigation Solution. Sanara’s pipeline also c…
In the news
Shareholder Alert: Ademi LLP investigates whether Sanara MedTech Inc. is obtaining a Fair Price for Public Shareholders ↗
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI ↗
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI ↗
Recent filings
Regulation FD Disclosure
Items 7.01
425 filing
Other Events
Items 8.01
Submission of Matters to a Vote of Security Holders · Other Events
Items 5.07, 8.01
4 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 71,088,648Source | 88,545,476Source | 69,146,387Source | 98,767,645Source | 73,383,605Source | 69,277,117Source | 96,378,581Source | 70,911,940Source | 72,944,071Source | 88,091,992Source | 73,871,149Source | 61,035,386Source |
| Property, Plant and Equipment, NetUSD | 417,208Source | 995,770Source | 426,934Source | 8,899,879Source | 1,116,266Source | 458,880Source | 2,056,121Source | 1,190,805Source | 456,962Source | 432,317Source | 1,257,956Source | 1,416,436Source |
| GoodwillUSD | 3,601,781Source | 3,601,781Source | 3,601,781Source | 3,601,781Source | 3,601,781Source | 3,601,781Source | 3,601,781Source | 3,601,781Source | 3,601,781Source | 3,601,781Source | 3,601,781Source | 3,601,781Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 21,100,783Source | 42,029,142Source | 17,277,013Source | 40,992,568Source | 42,977,404Source | 17,860,273Source | 42,013,997Source | 43,953,610Source | 18,640,673Source | 41,006,776Source | 44,926,061Source | 31,509,980Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 14,939,646Source | 16,277,189Source | 15,421,170Source | 16,958,744Source | 6,150,375Source | 13,594,459Source | 20,687,806Source | 2,828,234Source | 16,578,857Source | 15,878,295Source | 5,147,216Source | 8,958,995Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | — | 12,572,651Source | — | — | 13,617,407Source | — | — | — | — | — | 6,805,761Source |
| Inventory, NetUSD | 3,385,956Source | 3,008,349Source | 3,459,921Source | 3,511,850Source | 3,564,659Source | 3,120,795Source | 3,159,382Source | 4,229,150Source | 3,948,748Source | 2,753,032Source | 4,717,533Source | 3,549,000Source |
| Assets, CurrentUSD | 31,225,679Source | 31,908,408Source | 32,200,678Source | 33,669,456Source | 20,811,428Source | 31,197,982Source | 36,842,548Source | 17,186,779Source | 33,542,163Source | 33,305,988Source | 19,005,869Source | 20,616,509Source |
| Prepaid Expense and Other Assets, CurrentUSD | 714,115Source | 429,428Source | 741,733Source | 1,200,083Source | 489,240Source | 816,788Source | 1,091,039Source | 911,594Source | 948,620Source | 1,123,798Source | 608,411Source | 1,104,611Source |
| Operating Lease, Right-of-Use AssetUSD | 2,154,721Source | 1,688,963Source | 1,909,278Source | 1,088,149Source | 1,792,448Source | 1,993,850Source | 1,173,851Source | 1,894,687Source | 2,075,634Source | 1,447,907Source | 1,995,204Source | 806,402Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 64,948,114Source | 49,091,201Source | 61,211,927Source | 63,375,699Source | 31,981,610Source | 62,257,622Source | 59,711,004Source | 27,900,374Source | 67,014,295Source | 49,180,030Source | 29,283,132Source | 19,315,411Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 8,931Source | 8,743Source | 9,194Source | 8,904Source | 8,747Source | 9,166Source | 8,904Source | 8,623Source | 8,948Source | 8,754Source | 8,535Source | 8,300Source |
| Retained Earnings (Accumulated Deficit)USD | -73,693,846Source | -36,246,405Source | -74,891,763Source | -43,287,572Source | -33,387,960Source | -74,502,895Source | -41,311,569Source | -29,898,146Source | -75,303,042Source | -37,784,392Source | -28,036,814Source | -23,394,757Source |
| Stockholders' Equity Attributable to ParentUSD | 6,148,956Source | 39,783,866Source | 7,943,480Source | 35,399,413Source | 41,706,302Source | 7,028,515Source | 36,671,008Source | 43,290,685Source | 5,938,442Source | 39,403,573Source | 44,832,277Source | 41,827,530Source |
| Additional Paid in Capital, Common StockUSD | 79,833,871Source | 76,021,528Source | 82,826,049Source | 78,678,081Source | 75,085,515Source | 81,522,244Source | 77,973,673Source | 73,180,208Source | 81,232,536Source | 77,179,211Source | 72,860,556Source | 65,213,987Source |
| Liabilities and EquityUSD | 71,088,648Source | 88,545,476Source | 69,146,387Source | 98,767,645Source | 73,383,605Source | 69,277,117Source | 96,378,581Source | 70,911,940Source | 72,944,071Source | 88,091,992Source | 73,871,149Source | 61,035,386Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 17,357,969Source | 14,339,827Source | 12,493,991Source | 14,875,844Source | 11,565,787Source | 13,700,842Source | 13,281,055Source | 12,746,073Source | 18,626,530Source | 15,290,071Source | 13,767,877Source | 12,806,309Source |
| Operating Lease, Liability, CurrentUSD | 338,990Source | 439,129Source | 383,153Source | 182,935Source | 393,663Source | 367,945Source | 229,710Source | 377,273Source | 353,229Source | 358,687Source | 361,185Source | 313,933Source |
| Accounts Payable, CurrentUSD | — | — | 1,401,443Source | — | — | — | — | — | — | — | — | 1,392,701Source |
| Operating Lease, Liability, NoncurrentUSD | 1,963,475Source | 1,407,164Source | 1,669,529Source | 1,051,290Source | 1,512,584Source | 1,770,756Source | 1,087,947Source | 1,626,130Source | 1,868,703Source | 1,237,051Source | 1,737,445Source | 505,291Source |
| Other Liabilities, NoncurrentUSD | — | 2,006,000Source | — | 2,110,945Source | 2,654,001Source | — | 771,001Source | 2,777,835Source | — | 748,001Source | 2,723,001Source | 6,003,811Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -8,422Source | -329,591Source | -9,020Source | -7,467Source | -304,307Source | -9,020Source | -3,431Source | -279,119Source | -8,666Source | -491,611Source | -244,260Source | -107,555Source |
| Additional Financial Items | ||||||||||||
| Long-term Debt, Excluding Current MaturitiesUSD | 45,089,787Source | 30,076,715Source | 46,477,087Source | 44,216,662Source | 14,371,485Source | 46,226,422Source | 43,402,223Source | 8,767,991Source | 45,970,937Source | 30,689,290Source | 9,113,123Source | — |
| Long-term Debt, Current MaturitiesUSD | — | — | — | — | — | — | — | 928,571Source | — | — | 580,357Source | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 45,089,787Source | 30,076,715Source | 46,477,087Source | 44,216,662Source | 14,371,485Source | 46,226,422Source | 43,402,223Source | 8,767,991Source | 45,970,937Source | 30,689,290Source | 9,113,123Source | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -30,412,108Source | -2,883,052Source | -452,864Source | -2,018,398Source | 458,603Source | -3,527,383Source | -37,568,047Source | -9,911,898Source | -4,439,902Source | -8,092,328Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | 696,888Source | — | — | 587,252Source | 1,124,410Source | 3,945,965Source | 4,923,224Source | 3,675,026Source | 2,371,068Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 1,232,445Source | 1,025,431Source | — | — | 1,028,335Source | 1,304,904Source | 5,154,761Source | 4,436,048Source | 3,442,722Source | 2,702,633Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 1,709,332Source | -368,284Source | 114,690Source | 4,508,958Source | 1,821,895Source | 2,250,223Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -765,153Source | 605,628Source | 1,777,762Source | -1,442,744Source | 1,545,339Source | 517,271Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -1,433,365Source | 595,836Source | 813,999Source | -424,318Source | 531,380Source | -301,966Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | — | — | -5,844,796Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -2,465,407Source | -1,998,884Source | 6,786,629Source | -23,784Source | -3,245,556Source | -5,554,870Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -43,772Source | -5,179,855Source | -14,973,890Source | -6,611,643Source | -10,207,346Source | -3,511,630Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 43,772Source | 1,722,649Source | 4,625,650Source | 205,848Source | 265,246Source | 147,015Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -475,219Source | 11,988,250Source | 8,887,823Source | 17,366,506Source | 9,641,123Source | -627,346Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | — | — | — | -397,219Source | — | -546,994Source | -125,205Source | -135,794Source | -407,346Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -2,984,398Source | 4,809,511Source | 700,562Source | 10,731,079Source | -3,811,779Source | -9,693,846Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 1,516,747Source | 626,779Source | 3,351,791Source | 1,580,984Source | 283,948Source | 206Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | 143Source | 52,984Source | 48,792Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Accretion ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 284,540Source |
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | 130,174Source | — | — | — | 328,795Source | — | — |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | 73,541Source | 59,280Source | 279,905Source | 209,499Source | 5,138Source | — |
| Amortization of Intangible AssetsUSD | — | — | 569,342Source | 567,297Source | 583,260Source | 643,196Source | 545,399Source | 647,774Source | 2,486,302Source | 3,891,737Source | 3,218,888Source | 1,963,299Source |
| DepreciationUSD | — | — | 41,557Source | 129,592Source | — | 7,021Source | — | 5,461Source | 175,571Source | 1,031,487Source | 456,138Source | 407,769Source |
| Equity Method Investment, Other than Temporary ImpairmentUSD | — | — | — | — | — | — | — | — | 0Source | — | — | — |
| Equity Method Investment, Realized Gain (Loss) on DisposalUSD | — | — | — | — | — | — | — | — | — | — | 251,034Source | -1,040,311Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | — | — | — | — | — | — | 9,674Source | — | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | -1,376Source | — | — | 10,932Source | 10,932Source | — | — | -2,634Source |
| General and Administrative ExpenseUSD | — | — | — | — | 5,733,083Source | 3,956,788Source | 4,874,621Source | 4,045,211Source | 16,706,206Source | — | — | — |
| GoodwillUSD | — | — | 3,601,781Source | 3,601,781Source | 3,601,781Source | 3,601,781Source | 3,601,781Source | 3,601,781Source | 3,601,781Source | 3,601,781Source | 3,601,781Source | 3,601,781Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | 834,493Source | -180,488Source | -411,144Source | 500,259Source | 397,687Source | -620,566Source | -393,124Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | -31,246,601Source | -2,702,564Source | -41,720Source | -2,518,657Source | 60,916Source | -2,906,817Source | -37,174,923Source | — | — | — |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | -288,642Source | -31,448Source | -433,648Source | -195,482Source | -462,507Source | -143,608Source | -952,466Source | -90,007Source | — | -379,633Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | -48,380Source | — | -5,844,796Source |
| Inventory Write-downUSD | — | — | 117,615Source | 96,684Source | 68,022Source | 172,679Source | 62,800Source | 199,278Source | 582,046Source | 521,757Source | 406,812Source | 540,090Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -30,411,153Source | -2,857,768Source | -452,864Source | -2,014,362Source | 458,957Source | -3,527,177Source | -37,562,606Source | -9,664,547Source | -4,303,197Source | -7,937,497Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -955Source | -25,284Source | — | -4,036Source | -354Source | -206Source | -5,441Source | -247,351Source | -136,705Source | -154,831Source |
| Operating ExpensesUSD | — | — | 21,518,365Source | 18,901,075Source | 24,375,033Source | 21,379,661Source | 23,228,364Source | 20,773,599Source | 88,292,475Source | 85,247,998Source | 61,352,309Source | 51,714,428Source |
| Operating Lease, ExpenseUSD | — | — | 136,032Source | 121,126Source | 152,770Source | 128,629Source | 152,771Source | 131,568Source | 549,000Source | 555,192Source | 434,066Source | 297,136Source |
| Other Nonoperating Income (Expense)USD | — | — | -2,106,747Source | -959,025Source | -2,191,521Source | -1,987,050Source | -2,248,894Source | -1,446,096Source | -7,697,662Source | -3,196,424Source | -224,749Source | -1,704,690Source |
| Goodwill, Impairment Loss | — | — | —Source | —Source | — | — | — | —Source | — | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | —Source | —Source | — | —Source | —Source | —Source | — | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 26,333,819Source | 21,671,599Source | 28,136,757Source | 25,804,252Source | 27,798,534Source | 23,434,096Source | 103,117,982Source | 86,672,425Source | 64,989,842Source | 45,842,845Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Selling, General and Administrative ExpenseUSD | — | — | 19,877,875Source | 17,420,347Source | 22,601,690Source | 19,634,319Source | 21,881,520Source | 19,129,208Source | 78,716,999Source | 76,559,863Source | 56,994,753Source | 45,976,328Source |
| Operating Income (Loss)USD | — | — | 2,941,240Source | 778,537Source | 1,780,377Source | 2,487,309Source | 2,646,581Source | 825,530Source | 7,304,538Source | -6,715,474Source | -4,215,153Source | -12,232,434Source |
| Other Nonoperating Income (Expense)USD | — | — | -2,106,747Source | -959,025Source | -2,191,521Source | -1,987,050Source | -2,248,894Source | -1,446,096Source | -7,697,662Source | -3,196,424Source | -224,749Source | -1,704,690Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | -393,124Source | — | -4,439,902Source | -13,937,124Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | -48,380Source | — | -5,844,796Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -955Source | -25,284Source | — | -4,036Source | -354Source | -206Source | -5,441Source | -247,351Source | -136,705Source | -154,831Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -30,411,153Source | -2,857,768Source | -452,864Source | -2,014,362Source | 458,957Source | -3,527,177Source | -37,562,606Source | -9,664,547Source | -4,303,197Source | -7,937,497Source |
| Earnings Per Share, BasicUSD per share | — | — | -3.52Source | -0.34Source | -0.05Source | -0.23Source | 0.05Source | -0.41Source | -4.36Source | -1.14Source | -0.52Source | -1Source |
| Earnings Per Share, DilutedUSD per share | — | — | -3.4Source | -0.34Source | -0.05Source | -0.23Source | 0.05Source | -0.41Source | -4.36Source | -1.14Source | -0.52Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 8,646,668Source | 8,517,381Source | 8,662,671Source | 8,612,986Source | 8,706,678Source | 8,570,104Source | 8,623,028Source | 8,484,224Source | 8,278,949Source | 7,906,794Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 8,940,734Source | 8,517,381Source | 8,662,671Source | 8,927,060Source | 8,985,866Source | 8,570,104Source | 8,623,028Source | 8,484,224Source | 8,278,949Source | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 569,342Source | 567,297Source | 583,260Source | 643,196Source | 545,399Source | 647,774Source | 2,486,302Source | 3,891,737Source | 3,218,888Source | 1,963,299Source |
| Business Combination, Acquisition Related CostsUSD | — | — | 20,000Source | 24,812Source | 1,114,980Source | 4,826Source | — | 308,684Source | — | 1,350,289Source | — | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 610,899Source | 696,888Source | 619,111Source | 688,546Source | 587,252Source | 694,032Source | 2,661,873Source | 4,923,224Source | 3,675,026Source | 2,371,068Source |
| General and Administrative ExpenseUSD | — | — | — | — | 5,733,083Source | 3,956,788Source | 4,874,621Source | 4,045,211Source | 16,706,206Source | — | — | — |
| Gross ProfitUSD | — | — | 24,459,605Source | 19,679,612Source | 26,155,410Source | 23,866,970Source | 25,874,945Source | 21,599,129Source | 95,597,013Source | 78,532,524Source | 57,137,156Source | 39,481,994Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | 834,493Source | -180,488Source | -411,144Source | 500,259Source | 397,687Source | -620,566Source | -393,124Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -393,124Source | — | — | — |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | 0.1Source | -0.02Source | -0.05Source | 0.06Source | 0.04Source | -0.07Source | -0.05Source | — | — | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | 0.09Source | -0.02Source | -0.05Source | 0.05Source | 0.04Source | -0.07Source | -0.05Source | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | -31,246,601Source | -2,702,564Source | -41,720Source | -2,518,657Source | 60,916Source | -2,906,817Source | -37,174,923Source | — | — | — |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | -288,642Source | -31,448Source | -433,648Source | -195,482Source | -462,507Source | -143,608Source | -952,466Source | -90,007Source | — | -379,633Source |
| Interest ExpenseUSD | — | — | 1,818,105Source | 927,577Source | 1,810,311Source | 1,791,568Source | 1,799,345Source | 1,317,092Source | 6,759,800Source | 3,128,395Source | 475,783Source | 284,746Source |
| Interest Income, OtherUSD | — | — | — | — | 53,814Source | — | 12,958Source | 3,672Source | 3,672Source | 21,978Source | — | — |
| Operating ExpensesUSD | — | — | 21,518,365Source | 18,901,075Source | 24,375,033Source | 21,379,661Source | 23,228,364Source | 20,773,599Source | 88,292,475Source | 85,247,998Source | 61,352,309Source | 51,714,428Source |
| Operating Lease, ExpenseUSD | — | — | 136,032Source | 121,126Source | 152,770Source | 128,629Source | 152,771Source | 131,568Source | 549,000Source | 555,192Source | 434,066Source | 297,136Source |
| Research and Development ExpenseUSD | — | — | 1,029,591Source | 783,840Source | 1,154,232Source | 1,056,796Source | 759,592Source | 950,359Source | 5,072,483Source | 5,703,362Source | 4,132,425Source | 3,367,032Source |
| Selling and Marketing ExpenseUSD | — | — | — | — | 16,868,607Source | 15,677,531Source | 17,006,899Source | 15,083,997Source | 62,010,793Source | — | — | — |
| Goodwill, Impairment Loss | — | — | —Source | —Source | — | — | — | —Source | — | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | —Source | —Source | — | —Source | —Source | —Source | — | — | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
Filing attachments
ex99-1.htm · 10-Q · 2026-08-11
Exhibit 99.1 SANARA MEDTECH INC. INSIDER TRADING POLICY Background One of the principal purposes of the federal securities laws is the protection of investors in the U.S. securities markets through the assurance of fairness and the reduction of fraud in the markets. A major component of this effort is the prohibition on trading securities on the basis of or while in possession of material nonpublic information, called “insider trading.” Stated simply, insider trading occurs when a person wit…
Read attachment ↗ex99-1.htm · 425 · 2026-08-11
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) FORT WORTH, TX, August 11, 2026 (GLOBE NEWSWIRE) - Sanara MedTech Inc. (“Sanara,” “Sanara MedTech,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, today reported its financial result…
Read attachment ↗ex99-1.htm · 8-K · 2026-08-11
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) FORT WORTH, TX, August 11, 2026 (GLOBE NEWSWIRE) - Sanara MedTech Inc. (“Sanara,” “Sanara MedTech,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, today reported its financial result…
Read attachment ↗ex99-1.htm · 425 · 2026-07-29
Exhibit 99.1 MIMEDX to Acquire Sanara MedTech Transformational Combination Creates a Leading Regenerative Medicine Company Across Numerous Surgical Subspecialties Accelerates MIMEDX’s Strategic Priority to Expand Surgical Footprint, Nearly Doubling Surgical Revenue Immediately Accretive to Revenue Growth, Gross Margin and Adjusted EBITDA Margin Anticipates Over $20 Million in Run-Rate Cost Synergies Conference Call to Discuss Transaction Alongside MIMEDX’s Second Quarter 2026 Operating and…
Read attachment ↗ex99-1.htm · 8-K · 2026-07-29
EX-99.1 4 ex99-1.htm EX-99.1 Exhibit 99.1 MIMEDX to Acquire Sanara MedTech Transformational Combination Creates a Leading Regenerative Medicine Company Across Numerous Surgical Subspecialties Accelerates MIMEDX’s Strategic Priority to Expand Surgical Footprint, Nearly Doubling Surgical Revenue Immediately Accretive to Revenue Growth, Gross Margin and Adjusted EBITDA Margin Anticipates Over $20 Million in Run-Rate Cost Synergies Conference Call to Discuss Transaction Alongside MIMEDX’s …
Read attachment ↗ex99-1.htm · 8-K · 2026-05-11
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited) Net Revenue Growth of 19% and Net Profitability from Continuing Operations of $0.04 Per Fully Diluted Share for the Quarter FORT WORTH, TX, May 11, 2026 (GLOBE NEWSWIRE) - Sanara MedTech Inc. (“Sanara,” “Sanara MedTech,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to…
Read attachment ↗